Wells Fargo’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q4
Sell
-304,963
Closed -$5.75M 6510
2019
Q3
$5.75M Buy
304,963
+163,957
+116% +$3.09M ﹤0.01% 2401
2019
Q2
$1.66M Buy
141,006
+6,485
+5% +$76.3K ﹤0.01% 3460
2019
Q1
$1.84M Buy
134,521
+20,758
+18% +$283K ﹤0.01% 3403
2018
Q4
$1.17M Sell
113,763
-66,413
-37% -$681K ﹤0.01% 3647
2018
Q3
$3M Sell
180,176
-32,440
-15% -$540K ﹤0.01% 3035
2018
Q2
$3.36M Buy
212,616
+63,825
+43% +$1.01M ﹤0.01% 3001
2018
Q1
$1.89M Buy
148,791
+41,985
+39% +$533K ﹤0.01% 3386
2017
Q4
$1.22M Sell
106,806
-66,091
-38% -$757K ﹤0.01% 3724
2017
Q3
$2.12M Buy
172,897
+37,826
+28% +$463K ﹤0.01% 3230
2017
Q2
$1.55M Buy
135,071
+33,526
+33% +$384K ﹤0.01% 3342
2017
Q1
$2.11M Sell
101,545
-271,074
-73% -$5.64M ﹤0.01% 3130
2016
Q4
$7.75M Buy
372,619
+110,437
+42% +$2.3M ﹤0.01% 2040
2016
Q3
$8.59M Sell
262,182
-299,540
-53% -$9.82M ﹤0.01% 1852
2016
Q2
$14M Buy
561,722
+285,663
+103% +$7.13M 0.01% 1556
2016
Q1
$6.76M Buy
276,059
+6,285
+2% +$154K ﹤0.01% 2077
2015
Q4
$8.91M Buy
269,774
+200,707
+291% +$6.63M ﹤0.01% 1913
2015
Q3
$2.26M Sell
69,067
-1,857
-3% -$60.8K ﹤0.01% 2858
2015
Q2
$3.76M Buy
70,924
+12,369
+21% +$655K ﹤0.01% 2599
2015
Q1
$1.69M Buy
58,555
+51,312
+708% +$1.48M ﹤0.01% 3115
2014
Q4
$211K Sell
7,243
-20,982
-74% -$611K ﹤0.01% 4267
2014
Q3
$358K Sell
28,225
-10,098
-26% -$128K ﹤0.01% 4018
2014
Q2
$769K Buy
+38,323
New +$769K ﹤0.01% 3637